A new campaign for Astellas…
A new campaign for Astellas Pharma’s Izervay is aimed at [...]
Vertex expects $500 million in…
Vertex expects $500 million in 2026 from new products outside [...]
The regulatory environment in the…
The regulatory environment in the United States encountered by Moderna [...]
With sales of Immunocore’s…
With sales of Immunocore’s melanoma medicine steadily ticking up, an [...]
It’s déjà vu all over again….
It’s déjà vu all over again. Just as the IgA [...]
Late Thursday, PTC revealed that…
Late Thursday, PTC revealed that it withdrew its FDA application [...]
Messenger RNA specialist Moderna’s…
Messenger RNA specialist Moderna’s R&D spend sunk by nearly a [...]
Bayer has cooked up the next phase…
Bayer has cooked up the next phase of its “See [...]
Ultragenyx’s employees were…
Ultragenyx’s employees were already braced for changes as the biopharma [...]
Senate Questions Health Care Firm for Profiting Off Program Meant for Poor
The program was meant to help hospitals provide for poor [...]